Transcat (NASDAQ:TRNS) Announces Earnings Results

Transcat (NASDAQ:TRNS) released its quarterly earnings data on Tuesday. The scientific and technical instruments company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13, FiscalAI reports. The firm had revenue of $92.95 million during the quarter, compared to analyst estimates of $86.55 million. Transcat had a return on equity of 5.59% and a net margin of 0.99%.

Here are the key takeaways from Transcat’s conference call:

• Service revenue grew 27%, including 13% organic growth, marking Transcat’s 69th consecutive quarter of year-over-year service revenue growth. Management cited broad-based demand across regulated end markets and ongoing market-share gains.
• Service gross margin expanded 90 basis points to support a 31% increase in service gross profit, while service adjusted operating income rose 35%. Management expects further benefits from operating leverage, customer relationship maturation, pricing, mix optimization, and productivity initiatives.
• Management reaffirmed expectations for high-single-digit service organic growth and service gross-margin expansion for fiscal 2027. The company also plans to continue strategic acquisitions and grow its higher-margin rental business.
• Distribution gross margin declined 380 basis points year over year to 31.4%, primarily because the prior-year period benefited from unusually high vendor rebates. Diluted EPS was $0.14, pressured by acquisition-related amortization, stock compensation, interest expense, and executive transition costs.
• Transcat ended the quarter with $110.4 million of debt, $39.6 million of revolver availability, and a 2.19x leverage ratio. Management said its capital structure supports continued organic investment and acquisitions, including additional executive and M&A capabilities.

Transcat Price Performance

Shares of TRNS stock opened at $94.34 on Thursday. The firm’s 50 day moving average price is $89.11 and its two-hundred day moving average price is $79.29. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.99 and a current ratio of 2.33. Transcat has a 52-week low of $50.23 and a 52-week high of $95.22. The stock has a market cap of $883.01 million, a PE ratio of 252.59 and a beta of 0.68.

Institutional Trading of Transcat

Institutional investors and hedge funds have recently modified their holdings of the stock. Lazard Asset Management LLC bought a new position in shares of Transcat during the second quarter worth $54,000. Tower Research Capital LLC TRC increased its position in shares of Transcat by 245.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock valued at $97,000 after buying an additional 798 shares in the last quarter. Marshall Wace LLP acquired a new stake in Transcat during the 4th quarter worth $236,000. Balyasny Asset Management L.P. acquired a new stake in Transcat during the 4th quarter worth $247,000. Finally, Price T Rowe Associates Inc. MD raised its position in shares of Transcat by 8.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,265 shares of the scientific and technical instruments company’s stock worth $299,000 after purchasing an additional 432 shares during the period. 98.34% of the stock is owned by institutional investors.

Key Stories Impacting Transcat

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Transcat reported quarterly revenue of approximately $92.95 million, ahead of the $86.55 million analyst consensus, while reported EPS of $0.51 exceeded expectations of $0.38. The results highlight continued demand for the company’s measurement, calibration, and technical services. Transcat earnings report
• Positive Sentiment: Management is targeting high-single-digit organic growth in its Service segment and is emphasizing operational improvements, potentially supporting longer-term sales growth. Transcat service growth article
• Positive Sentiment: Operating cash flow rose sharply year over year, providing a brighter contrast to the weaker earnings results and helping support ongoing investment in the business. Transcat quarterly results analysis

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the stock. Weiss Ratings raised shares of Transcat from a “sell (d)” rating to a “sell (d+)” rating in a report on Thursday, May 28th. Northland Securities downgraded shares of Transcat from an “outperform” rating to a “market perform” rating and set a $95.00 price target for the company. in a report on Wednesday. Wall Street Zen upgraded shares of Transcat from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Finally, Zacks Research upgraded shares of Transcat from a “strong sell” rating to a “hold” rating in a research note on Friday, May 15th. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $105.50.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.